Supporting Information

Σχετικά έγγραφα
Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-Tetrabromofuran

Room Temperature Highly Diastereoselective Zn-Mediated. Allylation of Chiral N-tert-Butanesulfinyl Imines: Remarkable Reaction Condition Controlled

Supporting Information. Asymmetric Binary-acid Catalysis with Chiral. Phosphoric Acid and MgF 2 : Catalytic

Copper-catalyzed formal O-H insertion reaction of α-diazo-1,3-dicarb- onyl compounds to carboxylic acids with the assistance of isocyanide

Supporting Information

Highly enantioselective cascade synthesis of spiropyrazolones. Supporting Information. NMR spectra and HPLC traces

Supporting Information

Supporting Information

Hiyama Cross-Coupling of Chloro-, Fluoroand Methoxy- pyridyl trimethylsilanes : Room-temperature Novel Access to Functional Bi(het)aryl

and Selective Allylic Reduction of Allylic Alcohols and Their Derivatives with Benzyl Alcohol

A facile and general route to 3-((trifluoromethyl)thio)benzofurans and 3-((trifluoromethyl)thio)benzothiophenes

Direct Transformation of Ethylarenes into Primary Aromatic Amides with N-Bromosuccinimide and I 2 -aq NH 3

Supporting Information One-Pot Approach to Chiral Chromenes via Enantioselective Organocatalytic Domino Oxa-Michael-Aldol Reaction

Regioselectivity in the Stille coupling reactions of 3,5- dibromo-2-pyrone.

Supplementary Figure S1. Single X-ray structure 3a at probability ellipsoids of 20%.

Supporting Information

Chiral Brønsted Acid Catalyzed Enantioselective Intermolecular Allylic Aminations. Minyang Zhuang and Haifeng Du*

9-amino-(9-deoxy)cinchona alkaloids-derived novel chiral phase-transfer catalysts

Electronic Supplementary Information

First DMAP-mediated direct conversion of Morita Baylis. Hillman alcohols into γ-ketoallylphosphonates: Synthesis of

Supporting Information

Supporting Information

Supporting Information for

Supporting Information

Supplementary Material (ESI) for Organic & Biomolecular Chemistry This journal is (c) The Royal Society of Chemistry 2008

Supporting Information

Supporting Information

Copper-Catalyzed Oxidative Dehydrogenative N-N Bond. Formation for the Synthesis of N,N -Diarylindazol-3-ones

Mandelamide-Zinc Catalyzed Alkyne Addition to Heteroaromatic Aldehydes

Supporting information

Diastereoselective Access to Trans-2-Substituted Cyclopentylamines

Supplementary Information for

Crossed Intramolecular Rauhut-Currier-Type Reactions via Dienamine Activation

SUPPLEMENTARY INFORMATION

Asymmetric Synthesis of New Chiral β-amino Acid Derivatives by Mannich-type Reactions of Chiral N- Sulfinyl Imidates with N-Tosyl Aldimines

Enantioselective Organocatalytic Michael Addition of Isorhodanines. to α, β-unsaturated Aldehydes

Lewis Acid Catalyzed Propargylation of Arenes with O-Propargyl Trichloroacetimidate: Synthesis of 1,3-Diarylpropynes

Supplementary information

Supporting Information. Synthesis and biological evaluation of 2,3-Bis(het)aryl-4-azaindoles Derivatives as protein kinases inhibitors

Effect of uridine protecting groups on the diastereoselectivity

Construction of Cyclic Sulfamidates Bearing Two gem-diaryl Stereocenters through a Rhodium-Catalyzed Stepwise Asymmetric Arylation Protocol

Supporting Information. Synthesis and biological evaluation of nojirimycin- and

Divergent synthesis of various iminocyclitols from D-ribose

Supporting Information. Table of Contents. II. Experimental procedures. II. Copies of 1H and 13C NMR spectra for all compounds

Supporting Information

Palladium-Catalyzed C H Monoalkoxylation of α,β-unsaturated Carbonyl Compounds

Facile construction of the functionalized 4H-chromene via tandem. benzylation and cyclization. Jinmin Fan and Zhiyong Wang*

Tributylphosphine-Catalyzed Cycloaddition of Aziridines with Carbon Disulfide and Isothiocyanate

Aminofluorination of Fluorinated Alkenes

Supporting Information

Supporting information

The Supporting Information for

Supporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2006

Protease-catalysed Direct Asymmetric Mannich Reaction in Organic Solvent

Chiral Phosphoric Acid Catalyzed Asymmetric Synthesis of 2-Substituted 2,3-Dihydro-4-Quinolones by Protecting Group-Free Approach

Supporting Information. Microwave-assisted construction of triazole-linked amino acid - glucoside conjugates as novel PTP1B inhibitors

Supporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2006

Diastereo- and Enantioselective Propargylation of Benzofuranones. Catalyzed by Pybox-Copper Complex

Supporting Information. for. Angew. Chem. Int. Ed. Z Wiley-VCH 2003

Supporting Information for

Fluorinative Ring-opening of Cyclopropanes by Hypervalent Iodine Reagents. An Efficient Method for 1,3- Oxyfluorination and 1,3-Difluorination

Cu(I)-Catalyzed Asymmetric Multicomponent Cascade Inverse. Electron-Demand aza-diels-alder/nucleophilic Addition/Ring-Opening

Direct Palladium-Catalyzed Arylations of Aryl Bromides. with 2/9-Substituted Pyrimido[5,4-b]indolizines

Oxyhalogenation of thiols and disulfides into sulfonyl chlorides/ bromides in water using oxone-kx(x= Cl or Br)

Eur. J. Inorg. Chem WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2007 ISSN SUPPORTING INFORMATION

Supporting Information

Supporting Information

Supplementary Data. Engineering, Nanjing University, Nanjing , P. R. China;

Phosphorus Oxychloride as an Efficient Coupling Reagent for the Synthesis of Ester, Amide and Peptide under Mild Conditions

Supporting Information. Experimental section

Catalyst-free transformation of levulinic acid into pyrrolidinones with formic acid

Supporting Information

Synthesis and evaluation of novel aza-caged Garcinia xanthones

A New Type of Bis(sulfonamide)-Diamine Ligand for a Cu(OTf) 2 -Catalyzed Asymmetric Friedel-Crafts Alkylation Reaction of Indoles with Nitroalkenes

Supporting information

Total Synthesis of Echinopines A and B

Peptidomimetics as Protein Arginine Deiminase 4 (PAD4) Inhibitors

Supporting Information for

Synthesis of novel 1,2,3-triazolyl derivatives of pregnane, androstane and D-homoandrostane. Tandem Click reaction/cu-catalyzed D-homo rearrangement

Supporting Information. Consecutive hydrazino-ugi-azide reactions: synthesis of acylhydrazines bearing 1,5- disubstituted tetrazoles

Supporting Information for Iron-catalyzed decarboxylative alkenylation of cycloalkanes with arylvinylic carboxylic acids via a radical process

Supporting Information Table of Contents 1. General remarks...s1 2. Synthesis of catalyst L S1

Supporting Information

Supplementary Figure 1. (X-ray structures of 6p and 7f) O N. Br 6p

Supporting Information

Supplementary Figures

Synthesis of eunicellane-type bicycles embedding a 1,3- cyclohexadiene moiety

Supplementary Material

Novel and Selective Palladium-Catalyzed Annulation of 2-Alkynylphenols to Form 2-Substituted 3-Halobenzo[b]furans. Supporting Information

Vilsmeier Haack reagent-promoted formyloxylation of α-chloro-narylacetamides

Supplement: Intramolecular N to N acyl migration in conformationally mobile 1 -acyl-1- systems promoted by debenzylation conditions (HCOONH 4

The Free Internet Journal for Organic Chemistry

Supporting Information

Supporting Information. Toward the Total Synthesis of Amphidinolide N: Synthesis of the C8 C29 Fragment

Dearomative Indole (3+2) Reactions with Azaoxyallyl Cations New Method for the Synthesis of Pyrroloindolines. Supporting Information

New Glucuronic Acid Donors for the Modular Synthesis of Heparan Sulfate Oligosaccharides

Supporting Information

gem-dichloroalkenes for the Construction of 3-Arylchromones

A Cu/Pd Cooperative Catalysis for Enantioselective Allylboration of Alkenes

Supporting Information. Experimental section

Transcript:

Supporting Information Wiley-VCH 2007 69451 Weinheim, Germany

Supporting Information for Catalytic Enantioselective Conjugate Reduction of β,β- Disubstituted α,β-unsaturated sulfones Tomás Llamas, Ramón Gómez Arrayás, and Juan C. Carretero* Departamento de Química Orgánica. Facultad de Ciencias. Universidad Autónoma de Madrid. Cantoblanco. 28049 Madrid. Spain. Table of Contents 1. EXPERIMENTAL SECTION.. S 2 - General Methods... S 2 - Synthesis of methyl 2-pyridyl sulfone... S 2 - Typical procedure for the synthesis of b,b-disubstituted a,b-unsaturated sulfones... S 3 - Typical procedure for the asymmetric conjugate reduction... S 6 - Protocols for functionalization/desulfonylation... S 10 2. NMR SPECTRA OF NEW COMPOUNDS... S 14 S 1

1. EXPERIMENTAL SECTION General methods All the reactions were carried out in anhydrous solvents and under argon atmosphere. Melting points were taken in open-end capillary tubes. NMR spectra were recorded at 300 MHz ( 1 H), 75 MHz ( 13 C), at room temperature in CDCl 3 [calibrated at 7.26 ppm ( 1 H), and 77.0 ppm ( 13 C)]. Mass spectra (MS) were determined under electospray ionization (ESI). HPLC experiments were conducted using a Chiralpak IA column. Flash column chromatography was performed using silica gel Merk-60 (230-400 mesh). Below are the structures of the chiral ligands considered in the screening test to optimize the enantioselectivity of the conjugate reduction. (R)-Binap t-bu O OMe O Ph 2 P PPh 2 O P t-bu 2 O PPh 2 PCy 2 PPh 2 Fe PPh 2 NMe O P t-bu O PPh 2 2 Fe PPh 2 O OMe t-bu (R)-DTBM-Segphos 2 O (R)-Segphos (R,S)-Josiphos Taniaphos Synthesis of methyl 2-pyridyl sulfone DBU (1.1 eq.) MeI (1.1 eq.) N SH THF:CH 3 CN N SMe 0 ºC 25 ºC H 2 O 2 (3 eq.) Na 2 WO 4 2H 2 O (10 mol%) AcOEt:H 2 O (10:1) I, 92% 99% N SO 2 Me To a solution of 2-mercaptopyridine (5.0 g, 45 mmol) in THF (90 ml) and CH 3 CN (9 ml), 1 cooled to 0 ºC, was added DBU (6.6 ml, 49.5 mmol). The resulting mixture was stirred at 0 ºC for 5 min before MeI (3.1 ml, 49.5 mmol) was slowly added. Then, the ice bath was removed and the mixture was stirred for 4 h. The reaction mixture was washed with water (40 ml) and the aqueous layer was extracted with EtOAc (2 x 40 ml). The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 2:1) to afford the methyl 2-pyridyl sulfide (I) as a colourless oil; yield: 5.20 g (92%). 1 H NMR (300 MHz): d 8.42 (m, 1H), 7.47 (m, 1H), 7.16 (m, 1H), 6.96 (m, 1H), 2.55 (s, 3H). 13 C NMR (75 MHz): d 159.9, 149.3, 135.6, 121.3, 119.0, 13.1. 1 CH 3 CN was added to improve solubility of the sulfone S 2

To a solution of I (5.0 g, 39.9 mmol) in EtOAc (50 ml) was added H 2 O (6 ml) and Na 2 WO 4 2H 2 O (1.3 g, 4.0 mmol). The resulting mixture was cooled to 0 ºC before a 30% solution of H 2 O 2 (12.9 ml, 120 mmol) was added dropwise. The reaction was stirred at 0 ºC for 30 min and at rt for 1 h. Then it was cooled to 0 ºC and aqueous saturated NaHSO 3 (10 ml) was added slowly. The organic layer was separated and the aqueous layer was extracted with EtOAc (2 x 20 ml). The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromathograpy (n-hexane-etoac 2:1) to afford the sulfone as a colourless oil; yield: 6.3 g (99%). 1 H NMR (300 MHz): d 8.77-8.70 (m, 1H), 8.12-7.89 (m, 2H), 7.62-7.49 (m, 1H), 3.21 (s, 3H). 13 C NMR (75 MHz): d 157.8, 149.9, 138.3, 127.4, 121.0, 39.9. Typical procedure for the synthesis of b,b-disubstituted a,b-unsaturated sulfones: (E)-2-Phenyl-1-phenylsulfonyl-1-propene (1). To a solution of 3.2 mmol of methyl phenyl sulfone (0.5 g) in THF (20 ml), cooled to - 78 ºC, was added a 2.5 M solution of n-buli in hexane (1.4 ml, 3.5 mmol). The mixture was stirred at -78 ºC for 30 min before acetophenone (388 µl, 3.5 mmol) was added. The resulting orange solution was stirred at -78 ºC for 90 min, and then it was treated with aqueous saturated NH 4 Cl (10 ml). The organic layer was separated and the aqueous layer was extracted with EtOAc (2 x 20 ml). The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The crude resulting alcohol and DMAP (40 mg, 0.3 mmol) were dissolved in CH 2 Cl 2 (15 ml). The mixture was cooled to 0 ºC before Et 3 N (892 µl, 6.4 mmol) and TFAA (534 µl, 3.8 mmol) were successively added. The reaction mixture was stirred at 0 ºC for 30 min, allowed to reach rt and stirred at rt overnight. After hydrolysis with aqueous saturated NH 4 Cl (10 ml). The organic layer was separated and the aqueous layer was extracted with CH 2 Cl 2. The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 2:1) to afford the sulfone as a white solid; yield: 0.58 g (70%); mp = 78-79 ºC. 1 H NMR (300 MHz): d 8.00-7.98 (m, 1H), 7.98-7.95 (m, 1H), 7.66-7.52 (m, 3H), 7.40-7.35 (m, 5H), 6.61 (q, J= 1.1 Hz, 1H), 2.54 (d, J= 1.1 Hz, 3H). 13 C NMR (75 MHz): d?153.4, 142.1, 140.0, 133.1, 129.8, 129.1, 128.6, 127.3, 127.1, 126.2, 17.1. (E)-2-Phenyl-1-[(2-pyridyl)sulfonyl)]-1-propene (2a). White solid; mp = 82-83 ºC; yield: 0.52 g (63%). 1 H NMR (300 MHz): d 8.74 (ddd, J= 0.9, 1.7, 7.7 Hz, 1H), 8.17 (dt, J= 0.9, 7.7 Hz, 1H), 8.01 (dt, J= 1.7, 7.7 Hz, 1H), 7.57 (ddd, J= 1.0, 4.6, 7.8 Hz, S 3

1H), 7.52-7.28 (m, 5H), 6.74 (q, J= 1.0 Hz, 1H), 2.57 (d, J= 1.0 Hz, 3H). 13 C NMR (75 MHz): d?159.4, 155.0, 140.0, 138.0, 130.0, 128.7, 127.0, 126.3, 124.8, 121.7, 17.6. HRMS (FAB+) Calcd for C 14 H 14 NO 2 S, 260.0745; found, 260.0748. (E)-2-(p-Methoxyphenyl)-1-[(2-pyridyl)sulfonyl)]-1-propene (2b). Yellow solid; mp = 81-82 ºC; yield: 0.64 g (69%). 1 H NMR (300 MHz): d 8.76-8.72 (m, 1H), 8.18-8.13 (m, 1H), 7.95 (dt, J= 1.7, 7.7 Hz, 1H), 7.57 (ddd, J= 1.1, 4.5, 7.7 Hz, 1H), 7.43 (d, J= 9.0, 2H), 6.88 (d, J= 9.0, 2H), 6.72 (q, J= 1.0 Hz, 1H), 3.58 (s, 3H), 2.57 (d, J= 1.0 Hz, 3H). 13 C NMR (75 MHz): δ 161.2, 159.7, 155.3, 150.2, 137.9, 131.9, 127.9, 126.8, 122.8, 121.6, 114.0, 55.3, 17.3. (E)-2-(p-Nitrophenyl)-1-[(2-pyridyl)sulfonyl)]-1-propene (2c). Yellow solid; mp = 120-121 ºC; yield: 0.65 g (66%). 1 H NMR (300 MHz): δ 8.76-8.73 (m, 1H), 8.22 (d, J= 8.9 Hz, 2H), 8.18-8.14 (m, 1H), 7.99 (dt, J= 1.7, 7.7 Hz, 1H), 7.61-7.53 (m, 3H), 6.83 (q, J= 1.2 Hz, 1H), 2.61 (d, J= 1.2 Hz, 3H). 13 C NMR (75 MHz): δ 158.9, 153.2, 150.3, 148.4, 146.4, 138.2, 127.8, 127.4, 127.3, 123.9, 121.8, 17.8. (E)-2-(p-Bromophenyl-1-[(2-pyridyl)sulfonyl)]-1-propene (2d). Yellow solid; mp = 94-95 ºC; yield: 0.66 g (61%). 1 H NMR (300 MHz): d 8.77-8.73 (m, 1H), 8.18-8.13 (m, 1H), 7.97 (dt, J= 1.7, 7.7 Hz, 1H), 7.57-7.47 (m, 3H), 7.31 (d, J= 8.7, 2H), 6.76 (q, J= 1.0 Hz, 1H), 2.57 (d, J= 1.0 Hz, 3H). 13 C NMR (75 MHz): δ 159.3, 154.5, 150.3, 138.9, 138.1, 131.9, 127.9, 127.1, 125.3, 124.4, 121.7, 17.5. (E)-2-[(p-Trifluoromethyl)phenyl]-1-[(2-pyridyl)sulfonyl)]-1-propene (2e). White solid; mp = 63-64 ºC; yield: 0.42 g (51%). 1 H NMR (300 MHz): δ?8.75 (ddd, J= 0.9, 1.7, 4.7 Hz, 1H), 8.17 (dt, J= 1.0, 7.9 Hz, 1H), 7.98 (dt, J= 1.7, 7.8 Hz, 1H), 7.67-7.52 (m, 2H), 7.58-7.52 (m, 3H), 6.80 (q, J= 1.2 Hz, 1H), 2.61 (d, J= 1.2 Hz, 3H). 13 C NMR (75 MHz): δ?159.0, 154.2, 150.3, 143.7, 138.2, 131.5 (q, J C-F = 32.5 Hz), 127.2, 126.8, 126.7, 125.6 (q, J C-F = 3.9 Hz), 121.7, 17.6. (E)-2-(o-Methylphenyl)-1-[(2-pyridyl)sulfonyl)]-1-propene (2f). White solid; mp = 74-75 ºC; yield: 0.39 g (44%). 1 H NMR (300 MHz): δ 8.73 (ddd, J= 0.9, 1.7, 4.7 Hz, 1H), 8.13 (dt, J= 0.9, 7.8 Hz, 1H), 7.96 (dt, J= 1.7 y 7.7 Hz, 1H), 7.53 (ddd, J= 1.4, 4.6, 7.7 Hz, 1H), 7.21-7.10 (m, 3H), 7.05-7.00 (m, 1H), 6.38 (q, J= 1.3 Hz, 1H), 2.45 (d, J= 1.3 Hz, 3H), 2.21 (s, 3H). 13 C NMR (75 MHz): δ 159.3, 158.4, 150.1, 141.5, 138.0, 133.6, 130.5, 128.3, 127.0, 126.8, 126.5, 125.7, 121.4, 20.2, 19.3. S 4

(E)-2-(o-Bromophenyl-1-[(2-pyridyl)sulfonyl)]-1-propene (2g). White solid; mp = 126-127 ºC; yield: 0.48 g (45%). 1 H NMR (300 MHz): δ 8.89-8.77 (m, 1H), 8.20-8.15 (m, 1H), 7.99 (dt, J= 1.8, 7.7 Hz, 1H), 7.69-7.53 (m, 2H), 7.35-7.27 (m, 1H), 7.24-7.16 (m, 2H), 6.49 (q, J= 1.3 Hz, 1H), 2.54 (d, J= 1.3 Hz, 3H). 13 C NMR (75 MHz): δ 159.1, 157.1, 150.3, 142.6, 138.0, 133.1, 129.8, 128.5, 128.3, 127.5, 127.1, 121.8, 120.2, 20.0. (E)-2-(2-Naphtyl)-1-[(2-pyridyl)sulfonyl)]-1-propene (2h). White solid; mp = 127-128 ºC; yield: 0.58 g (59%). 1 H NMR (300 MHz): δ 8.80-8.74 (m, 1H), 8.22-8.16 (m, 1H), 8.01-7.94 (m, 2H), 7.89-7.80 (m, 3H), 7.57-7.49 (m, 4H), 6.91 (q, J= 1.2 Hz, 1H), 2.70 (d, J= 1.2 Hz, 3H). 13 C NMR (75 MHz): δ 159.5, 155.7, 150.3, 138.1, 137.1, 133.8, 132.9, 128.6, 128.4, 127.5, 127.2, 127.0, 126.7, 126.4, 125.1, 123.4, 121.7, 17.6. (E)- and (Z)-2-Phenyl-1-[(2-pyridyl)sulfonyl)]-1-butene [(E)-4 and (Z)-4). Purification of the crude mixture by flash chromatography (n-hexane-etoac 2:1) provided (E)-4 (0.26 g, 29%), followed by (Z)-4 (0.24 g, 27%), both as yellow oils. (E)- 4: 1 H NMR (300 MHz): δ 8.76-8.72 (m, 1H), 8.18-8.14 (m, 1H), 7.96 (dt, J= 1.6, 7.8 Hz, 1H), 7.55-7.49 (m, 1H), 7.40-7.36 (m, 5H), 6.64 (s, 1H), 3.11 (q, J= 7.7 Hz, 2H), 0.99 (t, J= 7.7 Hz, 3H). 13 C NMR (75 MHz): δ 162.1, 159.4, 150.2, 138.7, 138.0, 129.7, 128.6, 126.9, 126.7, 124.5, 121.6, 24.0, 13.1. (Z)-4: 1 H NMR (300 MHz): δ 8.67-8.64 (m, 1H), 7.60 (dt, J= 1.7, 7.7 Hz, 1H), 7.45 (d, J= 7.7 Hz, 1H), 7.38-7.32 (m, 1H), 7.23-7.13 (m, 3H), 6.99-6.94 (m, 2H), 6.71 (t, J= 1.3 Hz, 1H), 2.46 (dq, J= 1.3, 7.5 Hz, 2H), 1.06 (t, J= 7.5 Hz, 3H). 13 C NMR (75 MHz): δ 161.2, 158.4, 149.6, 137.2, 136.7, 127.9, 127.5, 127.2, 126.4, 125.7, 122.0, 33.7, 11.3. (E)- and (Z)-2-Methyl-1-[(2-pyridyl)sulfonyl)]-3-tetrahydropyranoxy-1-propene [(E)-5 and (Z)-5]. Purification of the crude mixture by flash chromatography (nhexane-etoac 2:1) provided (E)-5 (0.21 g, 22%), followed by (Z)-5 (0.25 g, 26%), both as colorless oils. (E)-5: 1 H NMR (300 MHz): δ 8.70 (d, J= 4.6 Hz, 1H), 8.06 (d, J= 7.9 Hz, 1H), 7.92 (dt, J= 1.7, 7.7 Hz, 1H), 7.49 (ddd, J= 1.0, 4.7, 7.8 Hz, 1H), 6.35 (q, J= 1.4 Hz, 1H), 4.72 (q, J= 6.9 Hz, 2H), 4.56 (t, J= 3.6 Hz, 1H) 3.82-3.72 (m, 1H), 3.48-3.40 (m, 1H), 2.02 (d, J= 0.9 Hz, 3H), 1.85-1.45 (m, 6H). 13 C NMR (75 MHz): δ 159.1, 157.8, 150.2, 138.5, 138.0, 127.0, 124.0, 121.6, 98.8, 65.0, 62.4, 30.4, 25.2, 22.1, 19.4. (Z)-5: 1 H NMR (300 MHz): δ 8.73 (ddd, J= 0.9, 1.6, 4.7 Hz, 1H), 8.11 (dt, J= 1.0, 7.9 Hz, 1H), 7.93 (dt, J= 1.7, 7.7 Hz, 1H), 7.51 (ddd, J= 1.2, 4.7, 7.6 Hz, 1H), 6.65 (q, J= 1.4 Hz, 1H), 4.62 (t, J= 3.1 Hz, 1H), 4.25 (dd, J= 1.6, 16.6 Hz, 1H), 3.96 (dd, J= S 5

1.6, 16.6 Hz, 1H), 3.82-3.72 (m, 1H), 3.55-3.45 (m, 1H), 2.14 (d, J= 1.2 Hz, 3H), 1.85-1.45 (m, 6H). 13 C NMR (75 MHz): δ 159.3, 155.9, 150.2, 137.9, 126.9, 122.1, 121.6, 98.1, 69.7, 62.0, 30.1, 25.1, 18.9, 15.1. (E)-2,3,3-Trimethyl-1-[(2-pyridyl)sulfonyl)]-1-butene (6). Yellow oil; yield: 0.46 g (60%). 1 H NMR (300 MHz): δ 8.73-8.70 (m, 1H), 8.12-8.08 (m, 1H), 7.93 (dt, J= 1.7, 7.7 Hz, 1H), 7.50 (ddd, J= 1.2, 4.7, 7.8, 1H), 6.40 (d, J= 1.0 Hz, 1H), 2.15 (d, J= 1.0 Hz, 3H), 1.09 (s, 9H). 13 C NMR (75 MHz): δ 167.4, 159.3, 149.9, 137.8, 126.7, 122.1, 121.4, 38.4, 27.9, 14.4. (E)-4-[(2-Pyridyl)sulfonylmethylene]chroman (7). White solid; mp = 138-139ºC; yield: 0.69 g (75%). 1 H NMR (300 MHz): δ 8.71 (ddd, J= 0.9, 1.7, 4.7 Hz, 1H), 8.12 (dt, J= 1.1, 7.9 Hz, 1H), 7.94 (dt, J= 1.6, 7.7 Hz, 1H), 7.53-7.47 (m, 2H), 7.32-7.27 (m, 1H), 6.94-6.85 (m, 3H), 4.26 (t, J= 5.9 Hz, 2H), 3.46-3.41 (m, 2H). 13 C NMR (75 MHz): δ 159.6, 156.9, 150.3, 148.7, 138.1, 132.9, 127.0, 125.1, 121.5, 121.1, 118.9, 118.3, 117.8, 65.2, 26.2. (E)-1-[(2-Pyridyl)sulfonylmethylene]indan (8). White solid; mp = 88-89 ºC; yield: 0.63 (73%). 1 H NMR (300 MHz): δ 8.72 (d, J= 4.5 Hz, 1H), 8.15 (d, J= 8.0 Hz, 1H), 7.94 (dt, J= 1.7, 7.9 Hz, 1H), 7.57-7.47 (m, 2H), 7.43-7.33 (m, 2H), 7.30-7.22 (m, 1H), 6.85 (t, J= 2.5 Hz, 1H), 3.45-3.37 (m, 2H), 3.10 (t, J= 6.2 Hz, 2H). 13 C NMR (75 MHz): δ 162.8, 159.6, 150.2, 149.6, 138.3, 137.9, 132.0, 127.0, 126.8, 125.6, 122.2, 121.5, 114.6, 30.4, 29.7. Typical procedure for the asymmetric conjugate reduction of a,b-unsaturated sulfones: (S)-2-phenyl-1-[(2-pyridyl)sulfonyl)]propane (3a). A solution of CuCl (1.0 mg, 0.01 mmol), tbuona (1.0 mg, 0.01 mmol), (R)-Binap (6.2 mg, 0.01 mmol), PhSiH 3 (100 µl, 0.8 mmol) and (E)-2a (51.8 mg, 0.2 mmol) in toluene (1 ml, 0.2 M) was stirred at room temperature for 24 h. Aqueous saturated NH 4 Cl (20 µl) was added before the mixture was filtered through a short pad of Celite with a thin layer of anhydrous MgSO 4 on the top, and the filtrate was concentrated. The residue was purified by flash cromathography (n-hexane-etoac 4:1) to afford sulfone 3a as a white solid; yield: 49.5 mg (95%); mp = 71-72 ºC. Analysis by HPLC with chiral stationary phase (Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 30.3 min for (R)- 20 isomer and 33.3 min for (S)-isomer, 210 nm) showed 94% ee ([α] D = +6 (c 1, CHCl 3 )). 1 H NMR (300 MHz): δ 8.63 (d, J= 4.7 Hz, 1H), 7.84 (d, J= 7.8 Hz, 1H), 7.78 S 6

(dt, J= 1.7, 7.7 Hz, 1H), 7.42 (ddd, J= 1.4, 4.7, 7.8 Hz, 1H), 7.19-7.05 (m, 5H), 3.89 (dd, J= 6.2, 13.9 Hz, 1H), 3.58-3.40 (m, 2H), 1.42 (d, J= 6.7 Hz, 3H). 13 C NMR (75 MHz): δ 157.5, 149.9, 143.3, 137.8, 128.4, 127.0. 126.9, 126.7, 122.0, 58.7, 35.0, 22.1. HRMS (FAB+) Calcd for C 14 H 16 NO 2 S, 262.0901; found, 262.0903. (S)-2-(p-Methoxyphenyl)-1-[(2-pyridyl)sulfonyl)]propane (3b). Colorless oil; yield: 92%. [α] 20 D = +7.5 (c 1, CHCl 3 ), 91% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 35.0 min (R)-isomer and 38.8 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.63 (ddd, J= 0.9, 1.5, 4.7 Hz, 1H), 7.85-7.74 (m, 2H), 7.42 (ddd, J= 1.6, 4.7, 7.1 Hz, 1H), 6.99 (d, J= 8.6 Hz, 2H), 6.67 (d, J= 8.6 Hz, 2H), 3.85 (dd, J= 6.8, 14.1 Hz, 1H), 3.73 (s, 3H), 3.55-3.36 (m, 2H), 1.39 (d, J= 6.9 Hz, 3H). 13 C NMR (75 MHz): δ 158.2, 157.6, 149.9, 137.7, 135.4, 127.9, 126.8, 122.0, 113.8, 58.9, 55.2, 34.2, 22.2. HRMS (FAB+) Calcd for C 15 H 18 NO 3 S, 291.0929; found, 291.0920. (S)-2-(p-Nitrophenyl)-1-[(2-pyridyl)sulfonyl)]propane (3c). White solid; yield: 93%; mp = 76-77 ºC. [α] 20 D = -4.9 (c 1.3, CHCl 3 ), 89% ee. HPLC: Daicel Chiralpak IA, i- PrOH-hexane 20/80, flow rate 0.6 ml/min, t R : 48.1 min (R)-isomer and 50.8 min (S)- isomer, 210 nm. 1 H NMR (300 MHz): δ 8.64 (ddd, J= 0.9, 1.4, 4.7 Hz, 1H), 8.03 (d, J= 8.8 Hz, 2H), 7.87 (dt, J= 1.4, 7.9 Hz, 1H), 7.82 (dt, J= 1.7 and 7.5 Hz, 1H), 7.46 (ddd, J= 1.5, 4.7, 7.4 Hz, 1H), 7.25 (d, J= 8.8 Hz, 2H), 3.96-3.85 (m, 1H), 3.69-3.56 (m, 2H), 1.46 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.4, 150.7, 150.0, 146.8, 138.0, 128.0, 127.2, 123.7, 121.8, 57.8, 34.9, 22.0. HRMS (FAB+) Calcd for C 14 H 15 N 2 O 4 S, 307.0674; found, 307.0680. (S)-2-(p-Bromophenyl-1-[(2-pyridyl)sulfonyl)]propane (3d). Colorless oil; yield: 92%. [α] 20 D = +8.5 (c 1.25, CHCl 3 ), 92% ee. HPLC: Daicel Chiralpak IA, i-prohhexane 10/90, 0.6 ml/min, t R : 32.2 min (R)-isomer and 36.8 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.64-8.60 (m, 1H), 7.81-7.77 (m, 2H), 7.48-7.42 (m, 1H), 7.24 (d, J= 8.4 Hz, 2H), 6.95 (d, J= 8.4 Hz, 2H), 3.89 (dd, J= 7.5, 14.2 Hz, 1H), 3.56-3.38 (m, 2H), 1.40 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.3, 149.9, 142.1, 137.8, 131.4, 128.8, 126.8, 121.9, 120.5, 58.4, 34.6, 22.0. HRMS (FAB+) Calcd for C 14 H 15 BrNO 3 S, 339.9929; found, 339.9925. (S)-1-[(2-Pyridyl)sulfonyl)]-2-[(p-trifluoromethyl)phenyl]propane (3e). Colorless oil; yield: 95%. [α] 20 D = +6.9 (c 1.9, CHCl 3 ), 92% ee. HPLC: Daicel Chiralpak IA, i- PrOH-hexane 10/90, 0.6 ml/min, t R : 27.6 min (R)-isomer and 30.5 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.61-8.57 (m, 1H), 7.76-7.72 (m, 2H), 7.43-7.34 (m, 3H), S 7

7.17 (d, J= 8.1 Hz, 2H), 3.96 (dd, J= 9.8, 16.3 Hz, 1H), 3.59-3.50 (m, 2H), 1.43 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.3, 149.9, 147.0, 137.8, 129.0 (q, J C-F = 32.5 Hz), 127.5, 127.0, 125.3 (q, J C-F = 3.8 Hz), 121.9, 58.1, 35.1, 22.1. HRMS (FAB+) Calcd for C 15 H 15 F 3 NO 2 S, 330.0697; found, 330.0689. (S)-2-(o-Methylphenyl)-1-[(2-pyridyl)sulfonyl)]propane (3f). Colourless oil; yield: 93%. [α] 20 D = +21.3 (c 1, CHCl 3 ), 93% ee. HPLC: Daicel Chiralpak IA, i-prohhexane 10/90, 0.6 ml/min, t R : 23.9 min (R)-isomer and 25.8 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.64 (ddd, J= 0.9, 1.5, 4.7 Hz, 1H), 7.86-7.74 (m, 2H), 7.42 (ddd, J= 1.4, 4.7, 7.4 Hz, 1H), 7.00-6.95 (m, 4H), 3.85 (dd, J= 6.4, 14.0 Hz, 1H), 3.75 (sextet, J= 6.6 Hz, 1H), 3.54 (dd, J= 7.1, 14.0 Hz, 1H), 2.30 (s, 3H), 1.39 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.6, 149.9, 141.6, 137.8, 135.1, 130.4, 126.9, 126.4, 126.2, 125.6, 121.8, 58.4, 29.8, 21.6, 19.3. HRMS (FAB+) Calcd for C 15 H 18 NO 2 S, 276.0980; found, 276.0982. (S)-2-(o-Bromophenyl-1-[(2-pyridyl)sulfonyl)]propane (3g). Colorless oil; yield: 90%. [α] 20 D = +25.4 (c 1.6, CHCl 3 ), 94% ee. HPLC: Daicel Chiralpak IA, i-prohhexane 10/90, 0.6 ml/min, t R : 29.9 min (R)-isomer and 33.0 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.65 (d, J= 4.6 Hz, 1H), 7.97 (d, J= 7.8 Hz, 1H), 7.84 (dt, J= 1.6, 7.8 Hz, 1H), 7.48-7.39 (m, 2H), 7.20-7.12 (m, 2H), 7.01-6.94 (m, 1H), 3.97-3.83 (m, 2H), 3.62-3.52 (m, 1H), 1.42 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.2, 150.0, 142.2, 137.9, 133.0, 128.2, 127.8, 127.7, 127.1, 123.7, 122.1, 57.5, 33.7, 21.0. HRMS (FAB+) Calcd for C 14 H 15 BrNO 2 S, 339.9929; found, 339.9933. (S)-2-(2-Naphtyl)-1-[(2-pyridyl)sulfonyl)]propane (3h). White solid; yield: 89%; mp = 97-98 ºC. [α] 20 D = +13.2 (c 0.5, CHCl 3 ), 70% ee. HPLC: Daicel Chiralpak IA, i- PrOH-hexane 10/80, 0.6 ml/min, t R : 28.6 min (R)-isomer and 33.7 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.50 (ddd, J= 0.9, 1.6, 4.6 Hz, 1H), 7.73-7.65 (m, 3H), 7.59 (d, J= 8.5 Hz, 1H), 7.51-7.46 (m, 2H), 7.45-7.39 (m, 2H), 7.21-7.14 (m, 2H), 4.10-3.97 (m, 1H), 3.70-3.55 (m, 2H), 1.50 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 157.3, 149.7, 140.3, 137.3, 133.1, 132.2, 128.2, 127.5, 127.4, 126.5, 126.0, 125.8, 125.6, 125.0, 121.9, 58.7, 35.3, 22.0. HRMS (FAB+) Calcd for C 18 H 18 NO 2 S, 312.0980; found, 312.0984. 20 (S)-2-Phenyl-1-[(2-pyridyl)sulfonyl)]butane [(S)-9]. Colorless oil; yield: 92%. [α] D = +20.3 (c 2, CHCl 3 ), 93% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 20.8 min (R)-isomer and 22.3 min (S)-isomer, 210 nm. 1 H NMR (300 S 8

MHz): δ 8.57 (d, J= 4.5 Hz, 1H), 7.72-7.68 (m, 2H), 7.39-7.32 (m, 1H), 7.10-7.04 (m, 3H), 7.00-6.95 (m, 2H), 3.94 (dd, J= 8.5, 14.6 Hz, 1H), 3.57 (dd, J= 5.6, 14.7 Hz, 1H), 3.23-3.11 (m, 1H), 1.93-1.80 (m, 1H), 1.71-1.58 (m, 1H), 0.76 (t, J= 7.4 Hz, 3H). 13 C NMR (75 MHz): δ 157.5, 149.8, 141.1, 137.6, 128.2, 127.8, 126.7, 126.6, 122.0, 57.5, 42.3, 29.4, 11.5. HRMS (FAB+) Calcd for C 15 H 18 NO 2 S, 276.0980; found, 276.0982. 20 (R)-2-Phenyl-1-[(2-pyridyl)sulfonyl)]butane [(R)-9]. Colorless oil; yield: 92%. [α] D = -19.6 (c 1.9, CHCl 3 ), 91% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 20.8 min (R)-isomer and 22.3 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.57 (d, J= 4.5 Hz, 1H), 7.72-7.68 (m, 2H), 7.39-7.32 (m, 1H), 7.10-7.04 (m, 3H), 7.00-6.95 (m, 2H), 3.94 (dd, J= 8.5, 14.6 Hz, 1H), 3.57 (dd, J= 5.6, 14.7 Hz, 1H), 3.23-3.11 (m, 1H), 1.93-1.80 (m, 1H), 1.71-1.58 (m, 1H), 0.76 (t, J= 7.4 Hz, 3H). 13 C NMR (75 MHz): δ 157.5, 149.8, 141.1, 137.6, 128.2, 127.8, 126.7, 126.6, 122.0, 57.5, 42.3, 29.4, 11.5. (2S)-2-Methyl-1-[(2-pyridyl)sulfonyl)]-3-tetrahydropyranoxypropane [(2S)-10]. Colorless oil; yield: 89%. [α] 20 D = +11.6 (c 1.4, CHCl 3 ), 91% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 30.1 and 34.4 min (2R)-isomers; 32.3 and 35.8 (2S)-isomers, 210 nm. 1 H NMR (300 MHz): δ 8.76 (d, J= 4.8 Hz, 1H), 8.11 (d, J= 7.9 Hz, 1H), 7.97 (dt, J= 1.6, 7.9 Hz, 1H), 7.55 (dd, J= 4.6, 7.6 Hz, 1H), 4.55-4.47 (m, 1H) 3.82-3.65 (m, 2H), 3.65-3.53 (m, 1H), 3.52-3.43 (m, 1H), 3.38 (dd, J= 4.8, 9.8 Hz, 1H), 3.32-3.20 (m, 1H), 2.47-2.32 (m, 1H), 1.85-1.42 (m, 6H), 1.12 (d, J= 6.7 Hz, 3H). 13 C NMR (75 MHz): δ 157.8, 150.1, 138.1, 127.2, 121.9, 98.9, 98.5, 71.1, 70.4, 62.1, 62.1, 55.0, 54.8, 30.4, 30.3, 29.2, 29.0, 25.3, 19.3, 19.2, 17.1, 17.0. (2R)-2-Methyl-1-[(2-pyridyl)sulfonyl)]-3-(tetrahydropyranoxy)propane [(2R)-10]. Colorless oil; yield: 91%. [α] 20 D = -12.0 (c 0.9, CHCl 3 ), 91% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 30.1 and 34.4 min [for the two (2R)-diastereoisomers]; 32.3 and 35.8 [for the two (2S)-diastereoisomers], 210 nm. 1 H NMR (300 MHz): δ 8.76 (d, J= 4.8 Hz, 1H), 8.11 (d, J= 7.9 Hz, 1H), 7.97 (dt, J= 1.6, 7.9 Hz, 1H), 7.55 (dd, J= 4.6, 7.6 Hz, 1H), 4.55-4.47 (m, 1H) 3.82-3.65 (m, 2H), 3.65-3.53 (m, 1H), 3.52-3.43 (m, 1H), 3.38 (dd, J= 4.8, 9.8 Hz, 1H), 3.32-3.20 (m, 1H), 2.47-2.32 (m, 1H), 1.85-1.42 (m, 6H), 1.12 (d, J= 6.7 Hz, 3H). 13 C NMR (75 MHz): δ 157.8, 150.1, 138.1, 127.2, 121.9, 98.9, 98.5, 71.1, 70.4, 62.1, 62.1, 55.0, 54.8, 30.4, 30.3, 29.2, 29.0, 25.3, 19.3, 19.2, 17.1, 17.0. S 9

(E)-1-[(2-Pyridyl)sulfonyl)]-2,3,3-(trimethyl)butane (11). Yellow oil; yield: 93%. [α] 20 D = +26.9 (c 2, CHCl 3 ), 91% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 16.6 min (R)-isomer and 18.8 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.75 (d, J= 4.2 Hz, 1H), 8.11 (d, J= 8.2 Hz, 1H), 7.96 (dt, J= 1.5, 7.8 Hz, 1H), 7.54 (dd, J= 5.0, 7.8 Hz, 1H), 3.62 (d, J= 13.9 Hz, 1H), 3.01 (dd, J= 10.0, 14.3 Hz, 1H), 1.94-1.82 (m, 1H), 1.07 (d, J= 6.9 Hz, 3H), 0.83 (s, 9H). 13 C NMR (75 MHz): δ. 157.7, 150.1, 138.0, 127.2, 122.1, 54.8, 37.6, 33.3, 26.8, 15.3. HRMS (FAB+) Calcd for C 12 H 20 NO 2 S, 242.1136; found, 242.1130. (S)-4-[(2-Pyridyl)sulfonylmethyl]chroman (12). Colorless oil; yield: 93%. [α] 20 D = - 19.6 (c 2, CHCl 3 ), 90% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, 0.6 ml/min, t R : 31.2 min (R)-isomer and 35.3 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.78 (d, J= 4.7 Hz, 1H), 8.15 (d, J= 7.8 Hz, 1H), 8.00 (dt, J= 1.5, 7.7 Hz, 1H), 7.58 (dd, J= 1.5, 7.7 Hz, 1H), 7.09 (d, J= 7.5 Hz, 2H), 6.89-6.75 (m, 2H), 4.29-4.10 (m, 2H), 3.89 (d, J= 11.8 Hz, 1H), 3.65-3.55 (m, 2H), 2.28 (d, J= 4.8 Hz, 2H). 13 C NMR (75 MHz): δ 157.7, 154.7, 150.2, 138.3, 128.9, 128.4, 127.5, 122.5, 121.9, 120.7, 117.3, 62.5, 57.1, 28.5, 26.7. HRMS (FAB+) Calcd for C 15 H 16 NO 3 S, 290.0773; found, 290.0780. (S)-1-[(2-Pyridyl)sulfonylmethyl]indan (13). Colorless oil; yield: 91%. [α] 20 D = +10.6 (c 1.9, CHCl 3 ), 90% ee. HPLC: Daicel Chiralpak IA, i-proh-hexane 10/90, flow rate 0.6 ml/min, t R : 34.1 min (R)-isomer and 37.4 min (S)-isomer, 210 nm. 1 H NMR (300 MHz): δ 8.77 (d, J= 4.9 Hz, 1H), 8.16 (d, J= 7.8 Hz, 1H), 7.99 (dt, J= 1.5, 7.6 Hz, 1H), 7.57 (dd, J= 4.6, 7.6 Hz, 1H), 7.25-7.15 (m, 4H), 3.97 (dd, J= 3.0, 14.0 Hz, 1H), 3.77-3.67 (m, 1H), 3.48 (dd, J= 10.2, 14.0 Hz, 1H), 3.00-2.80 (m, 2H), 2.50-2.37 (m, 1H), 2.05-1.90 (m, 1H). 13 C NMR (75 MHz): δ 157.6, 150.2, 143.6, 143.5, 138.2, 127.4, 127.2, 126.5, 124.7, 123.3, 122.0, 56.5, 38.9, 32.3, 31.3. Protocols for functionalization/desulfonylation (R)-1,3-Diphenylbutane (14). To a solution of sulfone 3a (50 mg, 0.19 mmol, 94% ee) in THF (5 ml), cooled to -78 ºC, was added a 2.5 M solution of n-buli in hexane (84 µl, 0.21 mmol). The resulting orange solution was stirred for 30 min at -78 ºC before it was added benzyl bromide (25 µl, 0.21 mmol). The mixture was stirred at -78 ºC for 2 h, and then aqueous saturated NH 4 Cl (10 ml) was added. The organic layer was S 10

separated and the aqueous layer was extracted with EtOAc (2 x 15 ml). The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The residue was dissolved in MeOH (5 ml) and treated with 5 % Na(Hg) (230 mg) and Na 2 HPO 4 (93 mg, 0.6 mmol). The resulting suspension was stirred for 5 h at rt before it was poured into CH 2 Cl 2 (10 ml), filtered and washed with water (2 x 5 ml). The aqueous phase was extracted with CH 2 Cl 2 (3 x 5 ml) and the combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 100:1), to afford 14 as a colorless oil; yield: 30 mg (75%). [α] 20 D = +9.2 (c 0.7, CHCl 3 ), 94% ee. 1 H NMR (300 MHz): δ 7.45-7.35 (m, 5H), 7.20-7.09 (m, 5H), 2.59 (sextuplet, J= 7.1 Hz, 1H), 2.48 (t, J= 7.9 Hz, 2H), 2.08-1.65 (m, 2H), 1.22 (d, J= 7.1 Hz, 3H). 13 C NMR (75 MHz): δ 139.7, 139.4. 128.7, 128.4, 128.3, 128.1 126.1, 125.8, 42.5, 41.4, 33.1, 21.2. HRMS (FAB+) Calcd for C 16 H 19, 211.1409; found, 211.1420. Ethyl (R)-3-phenylbutyrate (15). 2 To a solution of sulfone 3a (50 mg, 0.19 mmol, 94% ee) in THF (5 ml), cooled to -78 ºC, was added a 2.5 M solution of n-buli in hexane (84 µl, 0.21 mmol). The resulting orange solution was stirred at -78 ºC for 30 min before ethyl chloroformate (21 µl, 0.21 mmol) was added. The mixture was stirred at -78 ºC for 2 h, and then saturated aqueous NH 4 Cl (10 ml) was added. The organic phase was separated and the aqueous layer was extracted with EtOAc (2 x 10 ml). The combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was dissolved in THF (2 ml) and added to a suspension of activated Zn (350 mg) in THF (4 ml) and aqueous saturated NH 4 Cl (4 ml). The mixture was stirred for 12 h at rt before it was filtered through Celite and washed with CH 2 Cl 2 (2 x 10 ml). The combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 4:1) to afford 15 as a colorless oil; yield: 29.4 mg (80%). [α] 20 D = -17.9 (c 0.8, CHCl 3 ), 94% ee; [α] Lit D (for the (S)-isomer of 90% ee) = +19.0 (c 1.1, CHCl 3 ). 1 H NMR (300 MHz): δ 7.32-7.27 (m, 2H), 7.22-7.17 (m, 3H), 4.07 (q, J= 7.1 Hz, 2H), 3.28 (sextet, J= 7.6 Hz, 1H), 2.61 (dd, J= 7.0, 15.0 Hz, 1H), 2.53 (dd, J= 8.0, 15.0 Hz, 1H), 1.31 (d, J= 7.1 Hz, 3H), 1.18 (t, J= 7.1 Hz, 3H). 13 C NMR (75 MHz): δ 172.3, 145.7, 128.4, 126.7, 126.3, 60.2, 42.9, 36.5, 21.7, 14.1. 2 (S)-isomer: D. H. Appella, Y. Moritani, R. Shintani, E. M. Ferreira, S. L. Buchwald, J. Am. Chem. Soc. 1999, 121, 9473. S 11

(R)-1,3-Diphenylbutan-1-one (16). 3 To a solution of sulfone 3a (50 mg, 0.19 mmol, 94% ee) in THF (5 ml), cooled to -78 ºC, was added a 2.5 M solution of n-buli in hexane (84 µl, 0.21 mmol). The resulting orange solution was stirred for 30 min at -78 ºC before benzoyl chloride (24 µl, 0.21 mmol) was added. The resulting solution was stirred at -78 ºC for 2 h and then it was added aqueous saturated NH 4 Cl (10 ml). The organic phase was separated and the aqueous phase was extracted with EtOAc (2 x 10 ml). The combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was dissolved in THF (2 ml) and added to a suspension of Zn activated (350 mg) in THF (4 ml) and aqueous saturated NH 4 Cl (4 ml). The mixture was stirred for 12 h at rt before it was filtered through Celite and washed with CH 2 Cl 2 (2 x 10 ml). The combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 3:1), to afford 16 as a white solid; yield: 29.2 mg (69%); mp = 51-52 ºC. [α] 20 D = -16.2 (c 0.7, CHCl 3 ), 94% ee; [α] Lit D (for a sample of 82% ee) = -13.5 (c 1.0, CCl 4 ). HPLC: Daicel Chiralcel OD, i- PrOH-hexane 2/98, 1 ml/min, t R : 17.6 min (S)-isomer and 19.9 min (R)-isomer, 210 nm. 1 H NMR (300 MHz): δ 7.93 (dd, J= 0.9, 8.0 Hz, 2H), 7.57-7.52 (m, 1H), 7.44 (dt, J= 1.8, 8.2 Hz, 2H), 7.33-7.27 (m, 4H), 7.22-7.17 (m, 1H), 3.51 (sextet, J= 7.2 Hz, 1H), 3.31 (dd, J= 5.8, 16.5 Hz, 1H), 3.16 (dd, J= 8.1, 16.2 Hz, 1H), 1.34 (d, J= 6.8 Hz, 3H). 13 C NMR (75 MHz): δ 199.0, 146.5, 132.9, 128.5, 128.2, 128.0, 126.8, 126.2, 47.0, 35.5, 21.8. (1E,3R)-1,3-diphenyl-1-butene (17). 4 To a solution of sulfone 3a (46 mg, 0.18 mmol, 94% ee) in DME (5 ml), cooled to -78 ºC, was added a 0.5 M solution of KHMDS in toluene (0.72 ml, 0.36 mmol). The resulting orange solution was stirred at -78 ºC for 3 min before benzaldehyde (28 µl, 0.27 mmol) was added. The resulting solution was stirred at -78 ºC for 2 h, and then saturated aqueous NH 4 Cl (10 ml) was added. The organic phase was separated and the aqueous phase was extracted with EtOAc (2 x 10 ml). The combined organic phase was dried (MgSO 4 ), filtered and concentrated. The residue was purified by flash chromatography (n-hexane-etoac 100:1) to afford 17 as a colorless oil; yield: 32.5 mg (87%). [α] 20 D = +40.0 (c 0.8, CHCl 3 ), 94% ee; [α] Lit D (for a sample of 81% ee) = +32.0 (c 0.4, CHCl 3 ). HPLC: Daicel Chiralcel OD, i-proh- 3 Y. Kanazawa, Y. Tsuchiya, K. Kobayashi, T. Shiomi, J-i. Itho, M. Kikuchi, Y. Yamamoto, H. Nishiyama, Chem. Eur. J. 2006, 12, 63. 4 P. Mauleón; J. C. Carretero, Org. Lett. 2004, 6, 3195. S 12

hexane 0.5/99.5, flow rate 0.2 ml/min, t R : 28.4 min (S)-isomer and 30.9 min (R)- isomer, 210 nm. 1 H NMR (300 MHz): δ 7.41-7.20 (m, 10H), 6.44 (d, J= 4.6 Hz, 2H), 3.74-3.64 (m, 1H), 1.50 (d, J= 7.1 Hz, 3H). 13 C NMR (75 MHz): δ 145.6, 137.6, 135.2, 128.5, 128.4, 127.3, 127.0, 126.2, 126.1, 42.5, 21.2. HRMS (FAB+) Calcd for C 16 H 17, 209.1252; found, 209.1243. S 13

2. NMR SPECTRA OF NEW COM POUNDS Ph Me 1 SO 2 Ph S 14

Ph Me 2a SO 2 (2-Py) S 15

MeO Me SO 2 (2-Py) 2b S 16

O 2 N Me SO 2 (2-Py) 2c S 17

Br Me SO 2 (2-Py) 2d S 18

F 3 C Me SO 2 (2-Py) 2e S 19

Me SO 2 (2-Py) 2f S 20

Br Me 2g SO 2 (2-Py) S 21

Me SO 2 (2-Py) 2h S 22

Ph Et (E)-4 SO 2 (2-Py) S 23

Et Ph SO 2 (2-Py) (Z)-4 S 24

SO 2 (2-Py) O O (E)-5 S 25

SO 2 (2-Py) O O (Z)-5 S 26

SO 2 (2-Py) 6 S 27

SO 2 (2-Py) O 7 S 28

SO 2 (2-Py) 8 S 29

Ph Me SO 2 (2-Py) 3a S 30

MeO Me SO 2 (2-Py) 3b S 31

O 2 N Me SO 2 (2-Py) 3c S 32

Br Me SO 2 (2-Py) 3d S 33

F 3 C Me SO 2 (2-Py) 3e S 34

Me SO 2 (2-Py) 3f S 35

Br Me 3g SO 2 (2-Py) S 36

Me 3h SO 2 (2-Py) S 37

Et Ph 9 SO 2 (2-Py) S 38

SO 2 (2-Py) O O 10 S 39

SO 2 (2-Py) 11 S 40

SO 2 (2-Py) 12 O S 41

SO 2 (2-Py) 13 S 42

Ph Ph Me 14 S 43